Genotoxicity--threshold or not? Introduction of cases of industrial chemicals

Hermann M Bolt1

  • 1Institut für Arbeitsphysiologie an der Universität Dortmund, Ardeystr. 67, D-44139, Dortmund, Germany. bolt@ifado.de

Toxicology Letters
|April 5, 2003
PubMed

Insights

Many industrial carcinogens are regulated as genotoxic, but some only cause tumors at high doses. This study discusses new classifications and the debate around practical thresholds for carcinogenicity risk assessment.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Risk Assessment

Background:

  • Industrial carcinogens are often regulated as genotoxic compounds, with non-threshold principles applied for risk assessment.
  • The toxicological mechanisms underlying carcinogenicity are not always well understood.
  • Current carcinogen classification systems are under discussion, with new proposals emerging.

Purpose of the Study:

  • To discuss the classification of carcinogens, particularly genotoxic compounds.
  • To examine the concept of practical thresholds for carcinogenicity.
  • To review arguments for and against thresholds for specific industrial chemicals.

Main Methods:

  • Review of current scientific literature and regulatory discussions.
  • Analysis of proposed classification systems, including the German MAK-Commission's recommendations.
  • Summarization of arguments regarding thresholds for carcinogenicity of industrial chemicals like vinyl acetate, formaldehyde, and others.

Main Results:

  • New classifications distinguish between genotoxic and non-genotoxic carcinogens, with varying potency considerations.
  • The existence of practical thresholds for some genotoxic carcinogens is debated.
  • High-volume industrial chemicals like vinyl acetate present complex cases for risk assessment.

Conclusions:

  • Regulatory frameworks may need adjustment to account for carcinogens relevant only at high doses.
  • Further research into the mechanisms and thresholds of carcinogenicity is encouraged.
  • Distinguishing between genotoxic and non-genotoxic mechanisms is crucial for accurate risk assessment.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...